Discover the advantages of omega-3s combined with chiropractic rehabilitation for better recovery and wellness in your health routine.
Table of Contents
This educational post discusses the powerful role of omega-3 fatty acids in modulating inflammation, promoting tissue resolution, and supporting whole-body healing. It explains how EPA and DHA lead to specialized pro-resolving mediators such as resolvins, protectins, and maresins, based on the latest research by leading researchers using modern, evidence-based methods. These molecules actually stop inflammatory cascades, rather than simply suppressing them. The post discusses food sources and quality supplements that deliver these essential fats, outlines documented benefits to cardiovascular, neurological, joint, and immune health, and explains how combining omega-3 intake with integrative chiropractic care offers a synergistic, non-surgical strategy for people living with pain and discomfort. Readers will also learn about the multidisciplinary model at Injury Medical Clinic PA in El Paso, Texas, where Dr. Alexander Jimenez, D.C., APRN, FNP-BC, CFMP, IFMCP, ATN, CCST works with Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933), who is the Medical Director and Collaborative Physician. This discussion explores how chiropractic spinal care, functional medicine principles, rehabilitation, and medical oversight work together to address the root causes of chronic inflammation while supporting natural healing.
Many suffer from chronic stiffness, joint pain, or limited mobility and wonder why conventional approaches don’t always work. One simple answer lies in the balance of fats in the diet and in the mechanical integrity of the spine and soft tissues. Omega-3 fatty acids are long-chain polyunsaturated fats that the body can’t produce enough of on its own. The body has to get them from food or supplements. The most clinically important ones are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), mainly from marine sources and the plant precursor alpha-linolenic acid (ALA). When these fats are incorporated into cell membranes, they influence cell communication, the initiation of inflammation, and, most importantly, inflammation resolution.
Chronic low-grade inflammation is not the same as the temporary response that clears an infection or heals a cut. If resolution doesn’t occur, inflammatory signals continue, leading to pain, tissue stiffness, and slow recovery. Over the past 20 years, researchers such as Charles N. Serhan have found that omega-3s are more than anti-inflammatory; they provide the building blocks for specialized pro-resolving mediators (SPMs) that actively orchestrate cleanup. At the same time, integrative chiropractic care addresses mechanical sources of irritation, including joint restrictions, altered movement patterns, and protective muscle tension, which can perpetuate local and systemic inflammatory signaling. When these two approaches are combined under coordinated medical direction, patients often achieve a more complete restoration of function, without the need for long-term pharmaceuticals or invasive procedures.
This combined approach is standard at Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic. Dr. Jimenez offers evidence-based chiropractic and functional medicine care, emphasizing spinal biomechanics, neuromuscular re-education, and nutritional optimization. Dr. Maria Guadalupe Cardenas, MD, is an internist with over forty years of clinical experience and serves as the Medical Director and Collaborative Physician. She provides internal-medicine oversight for complex cases, medication management as indicated, and coordination of diagnostic evaluations. The outcome is a patient-centric pathway that addresses both the biochemical drivers of inflammation and structural contributors to pain.
After an injury or infection, cells release chemical messengers that cause inflammation. Phospholipase A2 releases arachidonic acid from membrane phospholipids. Cyclooxygenase and lipoxygenase enzymes then convert arachidonic acid into prostaglandins, thromboxanes, and leukotrienes. These molecules are needed for acute defense; they increase blood flow, recruit immune cells, and sensitize pain. In an ideal scenario, the body later switches to producing resolution mediators. Adding omega-3s to membranes alters the substrate pool so the same enzymes produce fewer inflammatory eicosanoids and more SPMs.
Incomplete resolution results in persistent neutrophils, persistent macrophages in a pro-inflammatory phenotype, and continued circulation of cytokines such as interleukin-6 and tumor necrosis factor-alpha. This state is associated with joint stiffness, muscle guarding, and increased pain perception. A recent pre-clinical study showed that mice fed a prophylactic omega-3-enriched diet developed less paw edema in an arthritis model and had more MerTK-positive, CD206-positive resolution-promoting macrophages (Nature Communications Biology, 2026). Joint lipid profiling revealed elevated levels of the E-series resolvins RvE2 and RvE4. Pharmacologically administered resolvins reduced arthritis severity and the release of pro-inflammatory mediators from synovial explants. Concomitantly, human data showed a similar reduction in monocyte adhesion molecule expression in blood samples from patients with arthritis with the same resolvins. These results suggest that blocking inflammation with nonsteroidal drugs is not the same as actively resolving it.
Once EPA and DHA enter cell membranes, several coordinated processes occur. They first compete with arachidonic acid for the same desaturase, cyclooxygenase, and lipoxygenase enzymes, thus decreasing the generation of highly inflammatory series-2 prostaglandins and series-4 leukotrienes. Second, they are direct precursors of SPMs. EPA leads to E-series resolvins, and DHA to D-series resolvins, protectins, and maresins. These lipid mediators have potent biological effects at picomolar to nanomolar concentrations, orders of magnitude lower than typical cytokine levels.
Resolvins prevent additional neutrophil entry into the tissue, stimulate macrophages to ingest apoptotic cells (efferocytosis), and promote the release of anti-inflammatory cytokines. Protectins and maresins promote tissue repair and restore barriers. A 2025 expert panel consensus on enteral nutrition highlighted that SPM biosynthesis is often compromised in disease states; supplying substrate alone may be inadequate if enzymatic conversion is impaired, underscoring the need for consistent intake and, in some cases, direct SPM-supporting strategies. Receptor-level actions further amplify this effect. Omega-3s activate the G-protein-coupled receptor GPR120 (also called FFAR4) on macrophages and disrupt the TAK1–NF-κB signaling pathway that drives cytokine production. They also bind to peroxisome-proliferator-activated receptors and can covalently bind cysteine residues on transcription factors, activating the Nrf2 antioxidant pathway while inhibiting NF-κB. The net result is a switch from a pro-inflammatory gene-expression program to one promoting resolution and tissue homeostasis.
A 2026 meta-analysis of 96 trials on EPA-to-DHA dosing ratios found that taking EPA plus DHA together reliably increases blood levels of these fats and decreases arachidonic acid, C-reactive protein, tumor necrosis factor-alpha, and interleukin-6, with the most consistent reductions in cytokines found with daily doses of 1–3 grams (Critical Reviews in Food Science and Nutrition, 2026). Ratios below 1.0 (more DHA relative to EPA) tended to produce greater cytokine suppression, while higher EPA ratios more effectively elevated the overall omega-3 index and lowered arachidonic acid. These dose- and ratio-dependent findings help clinicians to individualize recommendations, rather than applying a one-size-fits-all protocol.
Cardiovascular research remains one of the strongest. In the REDUCE-IT trial, purified EPA at 4 grams daily reduced major adverse cardiovascular events by 25 percent in high-risk patients. Larger meta-analyses of marine omega-3 supplementation have demonstrated modest reductions in myocardial infarction, coronary death, and total coronary heart disease. Mechanisms include improved endothelial function, lower triglycerides, decreased platelet aggregation, and less vascular inflammation.
Neurological benefits are mediated via DHA, a major constituent of the phospholipid content of neuronal membranes. Supplementation has been associated with increased membrane fluidity, support of synaptic plasticity, and production of neuroprotectins that prevent microglial over-activation. In a 2026 mouse model of lipopolysaccharide-induced neuroinflammation, DHA restored glutathione peroxidase activity, reduced malondialdehyde, and significantly increased resolvin D1 concentrations in both brain tissue and serum. Observational and interventional data also suggest that higher omega-3 status is associated with slower cognitive decline and lower risk of certain mood disorders. However, individual responses vary by baseline status, genetics, and concurrent dietary omega-6 load.
Individuals seeking non-surgical relief are especially interested in musculoskeletal and joint outcomes. A systematic review and meta-analysis of 41 randomized trials with 3,759 participants with chronic pain reported a moderate, clinically meaningful decrease in pain intensity (standardized mean difference –0.55) in 2025. Benefits were seen as early as 1 month and increased up to 6 months; lower daily doses (≤1.35 g) were at least as effective as higher doses. Subgroup analyses showed clear improvements in rheumatoid arthritis, migraine, and mixed chronic pain conditions. Previous rheumatoid arthritis reviews also found that omega-3-rich diets or supplements added to standard care were associated with decreased tender-joint counts, morning stiffness, and nonsteroidal anti-inflammatory drug use. The above-cited 2026 study on arthritis nonsteroidalides provides a cellular explanation: enrichment of resolution-phase macrophages and elevated levels of specific resolvins within the joint.
Also, noteworthy are emerging oncology observations. A pilot randomized trial presented in 2026 looked at 4 g EPA daily in 418 patients undergoing surgery for colorectal cancer that had spread to the liver. Five-year overall survival was 62 percent in the EPA group and 45 percent in the mineral-oil placebo group. Median progression-free survival was similar. The investigators hypothesized that improved host response to cancer-associated cachexia or increased immune surveillance may have been involved, patterns that echo those seen in some immunotherapy trials. The results are preliminary until published in a peer-reviewed journal and should be seen as hypothesis-generating rather than practice-changing. But the safety and tolerability of EPA, even in combination with other cancer treatments, still needs further investigation.
Other reported benefits include support for healthy triglyceride metabolism, modest reductions in blood pressure in hypertensive individuals, improved symptoms in some inflammatory skin and gut conditions, and potential modulation of asthma-related airway inflammation, particularly if intakes increase during pregnancy or early life. We would expect heterogeneity across the trials. Response is affected by genetic polymorphisms that affect fatty-acid desaturases, baseline omega-3 index, microbiome composition, and product quality. So, supplements with high quality, low oxidation, and verified EPA/DHA content are preferred.
Fish from marine sources are the most abundant natural source of preformed EPA and DHA. Fatty species such as salmon, mackerel, sardines, herring, and anchovies, when eaten regularly, typically provide 1 to 2 grams of combined EPA plus DHA per 3- to 4-ounce serving. Algal oil is a plant-based alternative for DHA (and sometimes EPA) that does not come from marine animals. ALA is found in plant foods such as flaxseed, chia seed, walnuts, and canola oil. The body converts ALA to EPA and DHA, but not very efficiently (usually less than 10 percent for EPA and even less for DHA). People who eat little or no fish usually need supplementation to get to therapeutic blood levels.
For anti-inflammatory purposes, a common supplemental range is 1-3 grams per day of combined EPA+DHA, which is consistent with meta-analytic data showing the greatest cytokine reductions in this range. Under medical supervision, researchers have studied higher doses up to 4 grams, notably in cardiology and oncology. Quality concerns include third-party testing for heavy metals and oxidation markers, the form (triglyceride vs. ethyl ester), and the EPA-to-DHA ratio matched to the clinical target. Krill phospholipid preparations offer bioavailability advantages, although evidence from head-to-head comparisons with high-quality fish oil is mixed. Supplementation, along with a diet that restricts excessive omega-6 intake (from refined seed oils and processed foods), further promotes a shift toward resolution pathways.
Integrative chiropractic care aims to restore optimal joint movement, reduce mechanical irritation of the spinal and peripheral nerves, and improve neuromuscular coordination. Spinal manipulative therapy is applying controlled force to joints that are restricted in their movement. Clinical practice guidelines and systematic reviews support its use for acute and chronic low-back pain and neck pain, with effect sizes comparable to other recommended conservative therapies such as exercise or non-steroidal medications for short-term pain relief. A 2019 review of 47 studies found spinal manipulation or mobilization provided short-term pain relief similar to non-steroidal medications for chronic low back pain and modestly better functional improvement. Military pragmatic trials have also shown that adding chiropractic care to standard medical management improves health-related quality of life, pain, and disability scores.
In addition to biomechanical realignment, emerging evidence suggests that spinal manipulative therapy may influence inflammatory and stress-related biomarkers. In a non-randomized clinical trial of patients with non-specific low-back pain, a short course of treatment reduced tumor necrosis factor-alpha, interleukin-6, and interferon-gamma production, with greater effects in the chronic-pain cohort. A pragmatic randomized trial in 2025 of 12 weeks of chiropractic spinal manipulation in adults with sub-clinical spinal pain reported increased levels of brain-derived neurotrophic factor and interleukin-6, and decreased levels of tumor necrosis factor-alpha at follow-up, indicating modulation of neuroplasticity and inflammatory tone. In previous studies, a protocol of nine lumbar manipulations tended to normalize interleukin-6 and high-sensitivity C-reactive protein toward control values in patients with chronic low-back pain. Biochemical shifts mediate the mechanical advantages. Increased joint mobility reduces local tissue stress, reduces protective muscle spasm, and may reduce segmental reflex irritation, which perpetuates nociceptive input.
Chiropractic protocols also often include soft-tissue techniques, therapeutic exercise, ergonomic education, and lifestyle counseling. It is not just about temporarily alleviating symptoms; i t is about restoring optimal movement patterns that limit ongoing micro-trauma. With fewer mechanical irritants, the biochemical environment created by sufficient omega-3 status is better able to resolve the remaining inflammation and to promote tissue repair.
Together, these modalities address both the chemical and mechanical drivers of chronic pain. SPMs from omega-3s clear out inflammatory cells and promote macrophage transition to a resolution phenotype. Chiropractic adjustments eliminate joint restrictions that continually provoke local cytokine release and nociceptor sensitization. In practice, chronic lumbar pain patients may show less muscle guarding after spinal care; elevated resolvins then help clear residual inflammatory debris and promote collagen remodeling in surrounding soft tissues. Over weeks to months, this dual action can lead to sustained improvements in pain scores, range of motion, and daily function.
This synergy is often evident in clinical observations at Injury Medical Clinic PA. Patients who follow a consistent omega-3 protocol (usually 1-2 grams total EPA plus DHA from a verified source) along with a course of spinal manipulative therapy and rehabilitative exercise report faster decreases in morning stiffness and greater tolerance for progressive loading. A functional-medicine assessment can also identify contributing factors, such as sleep disruption, micronutrient gaps, or gut-barrier issues, that may amplify systemic inflammation. Coordination of these issues with Dr. Cardenas will help ensure that any other medical issues such as high blood pressure, metabolic dysfunction, or medication interactions are appropriately managed to allow the non-operative plan to move forward safely.
The combined approach provides several practical advantages for people living with chronic musculoskeletal pain. It is non-pharmacologic, so it avoids the gastrointestinal, cardiovascular, and renal risks of long-term non-steroidal anti-inflammatory drug use. Second, it aims for resolution, not indefinite suppression, consistent with the body’s own healing timeline. Third, improved joint mobility and neuromuscular control decrease the mechanical load on local inflammation, creating a positive feedback loop. Meta-analytical evidence indicates that omega-3 supplementation alone can produce clinically meaningful reductions in pain within one to six months. When spinal care also improves function, patients often regain activities they had restricted or abandoned.
People recovering from personal injury incidents, sports strains, or work-related overuse also benefit. Improved spinal mechanics allow for more efficient rehab exercise.Omega-3-supported resolution of soft-tissue inflammation speeds the return to baseline tissue quality. Functional medicine would say that optimizing the omega-3 index also supports mitochondrial membrane integrity and reduces oxidative stress, both of which affect energy levels and recovery capacity. Within a few weeks of starting the integrated protocol, patients commonly report better sleep, less need for over-the-counter pain relief, and increased confidence in their mobility during daily activities.
Starting a sustainable routine starts with dietary foundations. If possible, try to eat two to three servings of fatty fish per week. Otherwise, choose an omega-3 supplement that has been third-party tested and contains 1-2 grams of combined EPA plus DHA. Take it with a meal that includes other fats to help with absorption. At the same time, get an evaluation with a chiropractor who specializes in integrative care. Initial visits include a detailed history, orthopedic and neurological examination and, as indicated, imaging or laboratory assessment coordinated with the medical director. Treatment frequency is tailored to the individual patient and is often two to three visits a week initially, then tapered as mobility and symptoms improve. Home exercises reinforce gains made in the clinic.
The way you live your life improves the outcome. Regular sleep helps produce more SPM and speeds spinal recovery. Avoid competition for resolution enzymes by reducing ultra-processed foods high in omega-6 fats. Stress management practices can reduce cortisol-driven inflammation. Re-evaluate the omega-3 index (blood test) and functional movement patterns from time to time – this allows the plan to be refined. At Injury Medical Clinic PA, we incorporate these into Collaborative Assessment Programs based on Institute for Functional Medicine principles, so nutritional, structural, and medical factors are addressed together.
Injury Medical Clinic PA is a multidisciplinary center that houses chiropractic care, functional medicine, rehabilitation, and internal-medicine supervision. Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, leads the clinical services, specializing in spinal and extremity adjustments, soft-tissue therapies, rehabilitative exercise, and targeted nutritional protocols, including omega-3 optimization. His dual licensure as a chiropractor and advanced practice registered nurse enables seamless coordination of hands-on care and broader health assessment. Dr. Maria Guadalupe Cardenas, MD, has over 40 years of internal medicine experience. As Medical Director and Collaborative Physician, she reviews complex medical histories, orders or interprets diagnostic studies, manages coexisting conditions,s and provides the necessary medical direction for integrative and personal injury cases. This is a common model in well-run injury and wellness clinics: the doctor provides diagnostic and pharmaceutical expertise, while the chiropractor provides specialized non-surgical spinal and rehabilitative care. The team is further supplemented by nutritionists, rehabilitation providers, and support staff to address the underlying causes of pain and inflammation.
The model is evidence-based and focuses on the body’s own healing capacity. Patients are given individualized plans that include spinal manipulative therapy to restore motion, omega-3 supplementation to provide resolution substrates, functional medicine interventions to correct metabolic or gastrointestinal imbalances, and medical monitoring to ensure safety. The goal is total, nonsurgical management of pain and discomfort that supports long-term wellness.
You start to see patterns in clinical practice. Those who correct a low omega-3 index while receiving spinal care often report earlier improvements in morning stiffness and activity tolerance than those who receive either intervention alone. Laboratory trends often include reductions in high-sensitivity C-reactive protein and increases in the omega-3 index that parallel functional gains. These observations align with mechanistic literature on SPM generation and biomarker changes reported after spinal manipulative therapy. The early oncology data from 2026 further illustrates the broad host-response potential of higher-dose EPA, further supporting the rationale for sufficient status even in patients facing systemic challenges. Ongoing research on optimal EPA-to-DHA ratios, SPM bioavailability, and combined mechanical and nutritional protocols will further refine these approaches.
Omega-3 fatty acids provide the molecular building blocks for the body to actively resolve inflammation, while integrative chiropractic care removes mechanical barriers that perpetuate pain and local cytokine production. Together, these provide a viable, evidence-based, non-operative option for individuals hoping to alleviate pain and resume greater function. At Injury Medical Clinic PA, this synergy is reflected in the combined expertise of Dr. Alexander Jimenez and Dr. Maria Guadalupe Cardenas, MD, through a multidisciplinary approach encompassing functional medicine, rehabilitation, and medical oversight. Readers are encouraged to discuss personalized dosing, product quality, and chiropractic evaluation with qualified clinicians so they can safely adapt the strategies outlined here to individual needs and health goals.
SEO Tags
omega-3 fatty acids, inflammation resolution, EPA DHA benefits, specialized pro-resolving mediators, chiropractic care El Paso, non-surgical pain relief, integrative chiropractic, Dr Alex Jimenez, Dr Maria Guadalupe Cardenas, Injury Medical Clinic PA, joint pain omega-3, spinal manipulation inflammation, functional medicine inflammation, omega-3 supplements dosage, resolvins arthritis, chronic pain management, El Paso chiropractor, omega-3 and chiropractic synergy, health wellness routine, medical director collaborative physician
General Disclaimer, Licenses and Board Certifications *
Professional Scope of Practice *
The information herein on "Chiropractic Rehabilitation: A Natural Approach Using Omega-3s" is not intended to replace a one-on-one relationship with a qualified health care professional or licensed physician and is not medical advice. We encourage you to make healthcare decisions based on your research and partnership with a qualified healthcare professional.
Blog Information & Scope Discussions
Welcome to El Paso's Premier Wellness and Injury Care Clinic & Wellness Blog, where Dr. Alex Jimenez, DC, FNP-C, a Multi-State board-certified Family Practice Nurse Practitioner (FNP-BC) and Chiropractor (DC), presents insights on how our multidisciplinary team is dedicated to holistic healing and personalized care. Our practice aligns with evidence-based treatment protocols inspired by integrative medicine principles, similar to those on this site and on our family practice-based chiromed.com site, focusing on naturally restoring health for patients of all ages.
Our areas of multidisciplinary practice include Wellness & Nutrition, Chronic Pain, Personal Injury, Auto Accident Care, Work Injuries, Back Injury, Low Back Pain, Neck Pain, Migraine Headaches, Sports Injuries, Severe Sciatica, Scoliosis, Complex Herniated Discs, Fibromyalgia, Chronic Pain, Complex Injuries, Stress Management, Functional Medicine Treatments, and in-scope care protocols.
Our information scope is multidisciplinary, focusing on musculoskeletal and physical medicine; wellness; contributing etiological viscerosomatic disturbances within clinical presentations; associated somato-visceral reflex clinical dynamics; subluxation complexes; sensitive health issues; and functional medicine articles, topics, and discussions.
We provide and present clinical collaboration with specialists from various disciplines. Each specialist follows their professional scope of practice and licensure jurisdiction. We use functional health & wellness protocols to treat and support care for musculoskeletal injuries or disorders.
Our videos, posts, topics, and insights address clinical matters and issues that directly or indirectly relate to our clinical scope of practice.
Our office has made a reasonable effort to provide supportive citations and has identified relevant research studies that support our posts. We provide copies of supporting research studies upon request to regulatory boards and the public.
For further discussion on how this information relates to specific care plans or treatment protocols, please ask Dr. Alex Jimenez, DC, APRN, FNP-BC, or contact us at 915-850-0900.
We are here to help you and your family.
Blessings
Dr. Alex Jimenez DC, MSACP, APRN, FNP-BC*, CCST, IFMCP, CFMP, ATN
Email: coach@elpasofunctionalmedicine.com
Multidisciplinary Licensing & Board Certifications:
Licensed as a Doctor of Chiropractic (DC) in Texas & New Mexico*
Chiropractic Licenses:
Texas DC License #: TX5807, Verified: TX5807
New Mexico DC License #: NM-DC2182, Verified: NM-DC2182
Nurse Practitioner Licenses:
Texas APRN License #: 1191402, Verified: 1191402 *
New Mexico CNP License #: 90560, Verified 90560
Florida APRN License #: 11043890, Verified: APRN11043890 *
Colorado License #: C-APN.0105610-C-NP, Verified: C-APN.0105610-C-NP
New York License #: N25929, Verified N25929
Georgia APRN License #: GAA-NP005701
Multi-State Advanced Practice Registered Nurse (APRN*) Texas & Multi-States
Multi-state Compact APRN License by Endorsement (43 States)
Compact Status: Multi-State License: Authorized to Practice in 43 States*
Nursing Licensure Compact: Updated Here
DEA Registration: (Drug Enforcement Agency Registered)
All medical (MDs) and family practice providers (FNP-APRN) are registered and licensed to offer various levels of medication.
Verify Providers Here
License Verification Link: Nursys License Verifier
* Prescriptive Authority Authorized (DEA Registered Providers). Call if Required
Board Certification:
ANCC FNP-BC: Board Certified Nurse Practitioner*
Education:
Graduate with Honors: ICHS: MSN-FNP (Family Nurse Practitioner Program)
Degree Granted. Master's in Family Practice, MSN Diploma (Cum Laude)
Dr. Alex Jimenez, DC, APRN, FNP-BC*, CFMP, IFMCP, ATN, CCST
(Board Certified: Family Practice Nurse Practitioner—Multistate)*
(Licensed Nurse Practitioner & Chiropractor - Multistate)*
Clinical Director
DC & FNP License (Review Above)
Digital Business Card
NPI: 1205907805
Dr. Maria Cardenas, MD
(Board Certified: Internal Medicine)
(Licensed Medical Doctor)
Medical Director, Clinical Director & Collaborative Physician
NPI # 1164426748
MD License #: J2933
Licenses and Board Certifications:
MD: Medical Doctor
DC: Doctor of Chiropractic
APRNP: Advanced Practice Registered Nurse
FNP-BC: Family Practice Specialization (Multi-State Board Certified)
FNP-BC: Family Practice Across Life Span (Neonatal to Geriatrics)
RN: Registered Nurse (Multi-State Compact License)
CFMP: Certified Functional Medicine Provider
MSN-FNP: Master of Science in Family Practice Medicine
MSACP: Master of Science in Advanced Clinical Practice
IFMCP: Institute of Functional Medicine
CCST: Certified Chiropractic Spinal Trauma
ATN: Advanced Translational Neutrogenomics
Family with Primary Care Focus (Family Nurse Practitioner or FNP)
Memberships & Associations:
TCA: Texas Chiropractic Association: Member ID: 104311
TNA: Texas Nurse Association: Member ID: 06458222
TNP: Texas Nurse Practitioner Association ID: 2025091511
AANP: American Association of Nurse Practitioners: Member ID: 2198960
ANA: American Nurses Association: Member ID: 06458222 (District TX01)
| Primary Taxonomy | Selected Taxonomy | State | License Number |
|---|---|---|---|
| No | 111N00000X - Chiropractor | NM | DC2182 |
| Yes | 111N00000X - Chiropractor | TX | DC5807 |
| Yes | 363LF0000X - Nurse Practitioner - Family | TX | 1191402 |
| Yes | 363LF0000X - Nurse Practitioner - Family | FL | 11043890 |
| Yes | 363LF0000X - Nurse Practitioner - Family | CO | C-APN.0105610-C-NP |
| Yes | 363LF0000X - Nurse Practitioner - Family | NY | N25929 |
| Yes | 363LF0000X - Nurse Practitioner - Family | NM | 90560 |
| Yes | 363LF0000X - Nurse Practitioner - Family | GA | GAA-NP005701 |
Dr. Alex Jimenez, DC, APRN, FNP-BC*, CFMP, IFMCP, ATN, CCST
(Board Certified: Family Practice Nurse Practitioner—Multistate)*
(Primary Care Across Lifespan—Neonatal / Pediatric / Adult / Geriatrics)
(Licensed Nurse Practitioner & Chiropractor - Multistate)*
Clinical Director
Digital Business Card
NPI: 1205907805
Dr. Maria Cardenas, MD
(Board Certified: Internal Medicine)*
(Licensed Medical Doctor)*
Medical Director, Clinical Director & Collaborative Physician
NPI # 1164426748
MD License #: J2933
📆 Schedule Appointment: Schedule 24/7 (Click Here)
Why Collision-Dated Biomarkers Are Required to Prove Traumatic Aggravation Under the Eggshell Plaintiff Rule A… Read More
Chronic Migraine, Hormonal Changes, and BOTOX: When Broader Medical Evaluation Matters Abstract Chronic migraine is… Read More
By Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST Read More
By Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST Read More
When Lab Results Reveal a Second Problem: Why Injury Recovery Sometimes Requires Broader Medical Evaluation… Read More
When Diabetes Complicates Injury Recovery: What Can Medical Experts Reasonably Conclude? After a rear-end collision… Read More